Mechanisms of kidney injury in lupus nephritis - the role of anti-dsDNA antibodies

Frontiers in Immunology

Volumn 6, Issue SEP, 2015, Pages

  Yung, Susan ^a   Chan, Tak Mao ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anti dsDNA antibodies; Cyclophosphamide; Fibrosis; Inflammation; Lupus nephritis; Mesangial cells; Mycophenolic acid; Proximal renal tubular epithelial cells

Indexed keywords

ALPHA ACTININ; CALRETICULIN; CORTICOSTEROID; CXCL1 CHEMOKINE; CYCLOPHOSPHAMIDE; DEOXYRIBONUCLEASE I; DOUBLE STRANDED DNA ANTIBODY; FIBRONECTIN; INTERLEUKIN 6; LIPOCORTIN 2; MYCOPHENOLIC ACID; MYOSIN I; PROTEIN P53; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL ACTIVATION; CELL PROLIFERATION; COMPLEMENT ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; EPITHELIUM CELL; FIBROGENESIS; HUMAN; IMMUNOFLUORESCENCE TEST; IMMUNOPATHOGENESIS; KIDNEY INJURY; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; ONCOGENE C MYC; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVIEW; SOMATIC MUTATION;

EID: 84946564455     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00475     Document Type: Review

References (135)

1. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med (2003) 349:1526-33. doi: 10.1056/NEJMoa021933.
2. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A. Fifty years of anti-ds DNA antibodies: are we approaching journey's end? Rheumatology (Oxford) (2007) 46:1052-6. doi:10.1093/rheumatology/kem112.
3. Chan TM, Leung JK, Ho SK, Yung S. Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. J Am Soc Nephrol (2002) 13:1219-29. doi:10.1097/01.ASN.0000014223.71109.13.
4. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med (2008) 358:929-39. doi:10.1056/NEJMra071297.
5. Hahn BH. Antibodies to DNA. N Engl J Med (1998) 338:1359-68. doi:10.1056/NEJM199805073381906.
6. Tsao BP, Ohnishi K, Cheroutre H, Mitchell B, Teitell M, Mixter P, et al. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J Immunol (1992) 149:350-8.
7. Vlahakos DV, Foster MH, Adams S, Katz M, Ucci AA, Barrett KJ, et al. Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int (1992) 41:1690-700. doi:10.1038/ki.1992.242.
8. Fenton K, Fismen S, Hedberg A, Seredkina N, Fenton C, Mortensen ES, et al. Anti-dsDNA antibodies promote initiation, and acquired loss of renal Dnase1 promotes progression of lupus nephritis in autoimmune (NZBxNZW)F1 mice. PLoS One (2009) 4:e8474. doi:10.1371/journal.pone.0008474.
9. Waldman M, Madaio MP. Pathogenic autoantibodies in lupus nephritis. Lupus (2005) 14:19-24. doi:10.1191/0961203305lu2054oa.
10. Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, et al. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. Arthritis Rheum (2006) 54:2198-210. doi:10.1002/art.21934.
11. Yung S, Chan TM. Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clin Dev Immunol (2012) 2012:139365. doi:10.1155/2012/139365.
12. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. Am J Pathol (2006) 168:1779-92. doi:10.2353/ajpath.2006.051329.
13. Mortensen ES, Rekvig OP. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes. J Am Soc Nephrol (2009) 20:696-704. doi:10.1681/asn.2008010112.
14. Putterman C. New approaches to the renal pathogenicity of anti-DNA antibodies in systemic lupus erythematosus. Autoimmun Rev (2004) 3:7-11. doi:10.1016/S1568-9972(03)00082-X.
15. Rouquette AM, Desgruelles C. Detection of antibodies to dsDNA: an overview of laboratory assays. Lupus (2006) 15:403-7. doi:10.1191/0961203306lu2324oa.
16. Riboldi P, Gerosa M, Moroni G, Radice A, Allegri F, Sinico A, et al. Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus? Autoimmunity (2005) 38:39-45. doi:10.1080/08916930400022616.
17. Smeenk RJ. Methodological update detection of antibodies to dsDNA: current insights into its relevance. Clin Exp Rheumatol (2002) 20:294-300.
18. Geisert M, Heicke B, Metzmann E, Zahn RK. Influence of molecular weight of DNA on the determination of anti-DNA antibodies in systemic lupus erythematosus (SLE) sera by radioimmunoassay. Nucleic Acids Res (1975) 2:521-35. doi:10.1093/nar/2.4.521.
19. Aarden LA, de Groot ER, Feltkamp TE. Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci (1975) 254:505-15. doi:10.1111/j.1749-6632.1975.tb29197.x.
20. Venner AA, Ibanez D, Gladman DD, Urowitz MB, MacKinnon A, Blasutig IM, et al. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity. Clin Biochem (2013) 46:317-20. doi:10.1016/j.clinbiochem.2012.12.004.
21. Jiang C, Foley J, Clayton N, Kissling G, Jokinen M, Herbert R, et al. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol (2007) 178:7422-31. doi:10.4049/jimmunol.178.11.7422.
22. Jiang C, Zhao ML, Scearce RM, Diaz M. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis. Arthritis Rheum (2011) 63:1086-96. doi:10.1002/art.30230.
23. Rahman A. Autoantibodies, lupus and the science of sabotage. Rheumatology (Oxford) (2004) 43:1326-36. doi:10.1093/rheumatology/keh354.
24. Rahman A, Giles I, Haley J, Isenberg D. Systematic analysis of sequences of anti-DNA antibodies-relevance to theories of origin and pathogenicity. Lupus (2002) 11:807-23. doi:10.1191/0961203302lu302rr.
25. Rahman A, Haley J, Radway-Bright E, Nagl S, Low DG, Latchman DS, et al. The importance of somatic mutations in the V(lambda) gene 2a2 in human monoclonal anti-DNA antibodies. J Mol Biol (2001) 307:149-60. doi:10.1006/jmbi.2000.4491.
26. Dema B, Pellefigues C, Hasni S, Gault N, Jiang C, Ricks TK, et al. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis. PLoS One (2014) 9:e90424. doi:10.1371/journal.pone.0090424.
27. Dema B, Charles N, Pellefigues C, Ricks TK, Suzuki R, Jiang C, et al. Immunoglobulin E plays an immunoregulatory role in lupus. J Exp Med (2014) 211:2159-68. doi:10.1084/jem.20140066.
28. Mostoslavsky G, Fischel R, Yachimovich N, Yarkoni Y, Rosenmann E, Monestier M, et al. Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry. Eur J Immunol (2001) 31:1221-7. doi:10.1002/1521-4141(200104)31:4<1221::AID-IMMU1221>3.0.CO;2-P.
29. Pickering MC, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies? Nat Rev Rheumatol (2010) 6:490-3. doi:10.1038/nrrheum.2010.56.
30. Leffler J, Bengtsson AA, Blom AM. The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis (2014) 73:1601-6. doi:10.1136/annrheumdis-2014-205287.
31. Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B. Anti-DNA antibodies cross-react with C1q. J Autoimmun (2013) 44:34-9. doi:10.1016/j.jaut.2013.06.002.
32. Foster MH, Cizman B, Madaio MP. Nephritogenic autoantibodies in systemic lupus erythematosus: immunochemical properties, mechanisms of immune deposition, and genetic origins. Lab Invest (1993) 69:494-507.
33. Yung S, Chan TM. Anti-DNA antibodies in the pathogenesis of lupus nephritis-the emerging mechanisms. Autoimmun Rev (2008) 7:317-21. doi:10.1016/j.autrev.2007.12.001.
34. Radic MZ, Weigert M. Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 12:487-520. doi:10.1146/annurev.iy.12.040194.002415.
35. Katz JB, Limpanasithikul W, Diamond B. Mutational analysis of an autoantibody: differential binding and pathogenicity. J Exp Med (1994) 180:925-32. doi:10.1084/jem.180.3.925.
36. Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Gueguen P, et al. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Arthritis Rheum (2006) 54:2523-32. doi:10.1002/art.22015.
37. Yung S, Cheung KF, Zhang Q, Chan TM. Anti-dsDNA antibodies bind to mesangial annexin II in lupus nephritis. J Am Soc Nephrol (2010) 21:1912-27. doi:10.1681/ASN.2009080805.
38. Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol (2003) 30:1495-504.
39. Raz E, Brezis M, Rosenmann E, Eilat D. Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney. J Immunol (1989) 142:3076-82.
40. Chan TM, Frampton G, Staines NA, Hobby P, Perry GJ, Cameron JS. Different mechanisms by which anti-DNA MoAbs bind to human endothelial cells and glomerular mesangial cells. Clin Exp Immunol (1992) 88:68-74. doi:10.1111/j.1365-2249.1992.tb03041.x.
41. Chan TM, Cheng IK. Identification of endothelial cell membrane proteins that bind anti-DNA antibodies from patients with systemic lupus erythematosus by direct or indirect mechanisms. J Autoimmun (1997) 10:433-9. doi:10.1006/jaut.1997.9998.
42. Chan TM, Cheng IK. A prospective study on anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Clin Immunol Immunopathol (1996) 78:41-6. doi:10.1006/clin.1996.0006.
43. Lai KN, Leung JC, Bik Lai K, Li PK, Lai CK. Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells. J Pathol (1996) 178:451-7. doi:10.1002/(SICI)1096-9896(199604)178:4<451::AID-PATH499>3.3.CO;2-G.
44. Deocharan B, Qing X, Lichauco J, Putterman C. Alpha-actinin is a cross-reactive renal target for pathogenic anti-DNA antibodies. J Immunol (2002) 168:3072-8. doi:10.4049/jimmunol.168.6.3072.
45. Sun KH, Liu WT, Tsai CY, Tang SJ, Han SH, Yu CL. Anti-dsDNA antibodies cross-react with ribosomal P proteins expressed on the surface of glomerular mesangial cells to exert a cytostatic effect. Immunology (1995) 85:262-9.
46. Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest (1997) 100:25-31. doi:10.1172/JCI119517.
47. Seddiki N, Nato F, Lafaye P, Amoura Z, Piette JC, Mazie JC. Calreticulin, a potential cell surface receptor involved in cell penetration of anti-DNA antibodies. J Immunol (2001) 166:6423-9. doi:10.4049/jimmunol.166.10.6423.
48. Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, Papalardo E, Vargas G, Deora AB, et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood (2009) 114:3074-83. doi:10.1182/blood-2008-11-188698.
49. Ma K, Simantov R, Zhang JC, Silverstein R, Hajjar KA, McCrae KR. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J Biol Chem (2000) 275:15541-8. doi:10.1074/jbc.275.20.15541.
50. Canas F, Simonin L, Couturaud F, Renaudineau Y. Annexin A2 autoantibodies in thrombosis and autoimmune diseases. Thromb Res (2015) 135:226-30. doi:10.1016/j.thromres.2014.11.034.
51. Zhou H, Yan Y, Xu G, Zhou B, Wen H, Guo D, et al. Toll-like receptor (TLR)-4 mediates anti-beta2GPI/beta2GPI-induced tissue factor expression in THP-1 cells. Clin Exp Immunol (2011) 163:189-98. doi:10.1111/j.1365-2249.2010.04291.x.
52. Martin M, Leffler J, Blom AM. Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells. J Biol Chem (2012) 287:33733-44. doi:10.1074/jbc. M112.341339.
53. Caster DJ, Korte EA, Merchant ML, Klein JB, Wilkey DW, Rovin BH, et al. Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis. Proteomics Clin Appl (2015). doi:10.1002/prca.201400175.
54. Salle V, Maziere JC, Smail A, Cevallos R, Maziere C, Fuentes V, et al. Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndrome. J Clin Immunol (2008) 28:291-7. doi:10.1007/s10875-008-9188-1.
55. Yung S, Tsang RC, Leung JK, Chan TM. Increased mesangial cell hyaluronan expression in lupus nephritis is mediated by anti-DNA antibody-induced IL-1beta. Kidney Int (2006) 69:272-80. doi:10.1038/sj.ki.5000042.
56. Yung S, Zhang Q, Zhang CZ, Chan KW, Lui SL, Chan TM. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid. Arthritis Rheum (2009) 60:2071-82. doi:10.1002/art.24573.
57. Alarcon-Segovia D, Llorente L. Antibody penetration into living cells. IV. Different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T gamma cells. Clin Exp Immunol (1983) 52:365-71.
58. Alarcon-Segovia D. Antinuclear antibodies: to penetrate or not to penetrate, that was the question. Lupus (2001) 10:315-8. doi:10.1191/096120301669579565.
59. Madaio MP, Yanase K. Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications. J Autoimmun (1998) 11:535-8. doi:10.1006/jaut.1998.0217.
60. Alarcon-Segovia D, Ruiz-Arguelles A, Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature (1978) 271:67-9. doi:10.1038/271067a0.
61. Lisi S, Sisto M, Soleti R, Saponaro C, Scagliusi P, D'Amore M, et al. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjogren's syndrome and apoptosis in human salivary gland cell line A-253. J Oral Pathol Med (2007) 36:511-23. doi:10.1111/j.1600-0714.2007.00563.x.
62. Koscec M, Koren E, Wolfson-Reichlin M, Fugate RD, Trieu E, TargoffIN, et al. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture. J Immunol (1997) 159:2033-41.
63. Seret G, Canas F, Pougnet-Di Costanzo L, Hanrotel-Saliou C, Jousse-Joulin S, Le Meur Y, et al. Anti-alpha-actinin antibodies are part of the anti-cell membrane antibody spectrum that characterize patients with lupus nephritis. J Autoimmun (2015) 61:54-61. doi:10.1016/j.jaut.2015.05.009.
64. Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J Biol Chem (1994) 269:21191-7.
65. Otey CA, Carpen O. Alpha-actinin revisited: a fresh look at an old player. Cell Motil Cytoskeleton (2004) 58:104-11. doi:10.1002/cm.20007.
66. Zhao Z, Deocharan B, Scherer PE, Ozelius LJ, Putterman C. Differential binding of cross-reactive anti-DNA antibodies to mesangial cells: the role of alpha-actinin. J Immunol (2006) 176:7704-14. doi:10.4049/jimmunol.176.12.7704.
67. Deocharan B, Zhou Z, Antar K, Siconolfi-Baez L, Angeletti RH, Hardin J, et al. Alpha-actinin immunization elicits anti-chromatin autoimmunity in nonautoimmune mice. J Immunol (2007) 179:1313-21. doi:10.4049/jimmunol.179.2.1313.
68. Mason LJ, Ravirajan CT, Rahman A, Putterman C, Isenberg DA. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Arthritis Rheum (2004) 50:866-70. doi:10.1002/art.20103.
69. Zhao Z, Weinstein E, Tuzova M, Davidson A, Mundel P, Marambio P, et al. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Arthritis Rheum (2005) 52:522-30. doi:10.1002/art.20862.
70. Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, et al. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther (2009) 11:R154. doi:10.1186/ar2831.
71. Mjelle JE, Rekvig OP, Van Der Vlag J, Fenton KA. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens. Autoimmunity (2011) 44:373-83. doi:10.3109/08916934.2010.541170.
72. Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Arthritis Rheum (2006) 54:914-26. doi:10.1002/art.21622.
73. Berden JH, Licht R, van Bruggen MC, Tax WJ. Role of nucleosomes for induction and glomerular binding of autoantibodies in lupus nephritis. Curr Opin Nephrol Hypertens (1999) 8:299-306. doi:10.1097/00041552-199905000-00005.
74. van Bavel CC, Fenton KA, Rekvig OP, van der Vlag J, Berden JH. Glomerular targets of nephritogenic autoantibodies in systemic lupus erythematosus. Arthritis Rheum (2008) 58:1892-9. doi:10.1002/art.23626.
75. D'Andrea DM, Coupaye-Gerard B, Kleyman TR, Foster MH, Madaio MP. Lupus autoantibodies interact directly with distinct glomerular and vascular cell surface antigens. Kidney Int (1996) 49:1214-21. doi:10.1038/ki.1996.175.
76. Blatt NB, Glick GD. Anti-DNA autoantibodies and systemic lupus erythematosus. Pharmacol Ther (1999) 83:125-39. doi:10.1016/S0163-7258(99)00022-4.
77. Krishnan MR, Wang C, Marion TN. Anti-DNA autoantibodies initiate experimental lupus nephritis by binding directly to the glomerular basement membrane in mice. Kidney Int (2012) 82:184-92. doi:10.1038/ki.2011.484.
78. Yu CL, Sun KH, Tsai CY, Hsieh SC, Yu HS. Anti-dsDNA antibody up-regulates interleukin 6, but not cyclo-oxygenase, gene expression in glomerular mesangial cells: a marker of immune-mediated renal damage? Inflamm Res (2001) 50:12-8. doi:10.1007/s000110050718.
79. Yu CL, Huang MH, Tsai CY, Tsai YY, Tsai ST, Sun KH, et al. The effect of human polyclonal anti-dsDNA autoantibodies on apoptotic gene expression in cultured rat glomerular mesangial cells. Scand J Rheumatol (1998) 27:54-60. doi:10.1080/030097498441182.
80. Zhang Y, Yang J, Jiang S, Fang C, Xiong L, Cheng H, et al. The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells. J Clin Immunol (2012) 32:1270-8. doi:10.1007/s10875-012-9724-x.
81. Munoz LE, Lauber K, Schiller M, Manfredi AA, Herrmann M. The role of defective clearance of apoptotic cells in systemic autoimmunity. Nat Rev Rheumatol (2010) 6:280-9. doi:10.1038/nrrheum.2010.46.
82. Shao WH, Cohen PL. Disturbances of apoptotic cell clearance in systemic lupus erythematosus. Arthritis Res Ther (2011) 13:202. doi:10.1186/ar3206.
83. Madaio MP, Fabbi M, Tiso M, Daga A, Puccetti A. Spontaneously produced anti-DNA/DNase I autoantibodies modulate nuclear apoptosis in living cells. Eur J Immunol (1996) 26:3035-41. doi:10.1002/eji.1830261232.
84. Fismen S, Thiyagarajan D, Seredkina N, Nielsen H, Jacobsen S, Elung-Jensen T, et al. Impact of the tumor necrosis factor receptor-associated protein 1 (Trap1) on renal DNaseI shutdown and on progression of murine and human lupus nephritis. Am J Pathol (2013) 182:688-700. doi:10.1016/j.ajpath.2012.11.013.
85. Thiyagarajan D, Fismen S, Seredkina N, Jacobsen S, Elung-Jensen T, Kamper AL, et al. Silencing of renal DNaseI in murine lupus nephritis imposes exposure of large chromatin fragments and activation of toll like receptors and the Clec4e. PLoS One (2012) 7:e34080. doi:10.1371/journal.pone.0034080.
86. Zykova SN, Tveita AA, Rekvig OP. Renal Dnase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One (2010) 5:e12096. doi:10.1371/journal.pone.0012096.
87. Napirei M, Karsunky H, Zevnik B, Stephan H, Mannherz HG, Moroy T. Features of systemic lupus erythematosus in Dnase1-deficient mice. Nat Genet (2000) 25:177-81. doi:10.1038/76032.
88. Chitrabamrung S, Rubin RL, Tan EM. Serum deoxyribonuclease I and clinical activity in systemic lupus erythematosus. Rheumatol Int (1981) 1:55-60. doi:10.1007/BF00541153.
89. Perez de Lema G, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J Am Soc Nephrol (2001) 12:1369-82.
90. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis (1996) 27:640-6. doi:10.1016/S0272-6386(96)90097-9.
91. Tesch GH, Maifert S, Schwarting A, Rollins BJ, Kelley VR. Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med (1999) 190:1813-24. doi:10.1084/jem.190.12.1813.
92. Zhang H, Zhao C, Wang S, Huang Y, Wang H, Zhao J, et al. Anti-dsDNA antibodies induce inflammation via endoplasmic reticulum stress in human mesangial cells. J Transl Med (2015) 13:178. doi:10.1186/s12967-015-0536-7.
93. Rovin BH, Tan LC. Role of protein kinase pathways in IL-1-induced chemoattractant expression by human mesangial cells. Kidney Int (1994) 46:1059-68. doi:10.1038/ki.1994.367.
94. Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis. Cytokine (2013) 62:244-52. doi:10.1016/j.cyto.2013.03.016.
95. Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, Miller N, et al. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest (2004) 113:1722-33. doi:10.1172/JCI200419139.
96. McHale JF, Harari OA, Marshall D, Haskard DO. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol (1999) 163:3993-4000.
97. Boswell JM, Yui MA, Burt DW, Kelley VE. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol (1988) 141:3050-4.
98. Brennan DC, Yui MA, Wuthrich RP, Kelley VE. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury. J Immunol (1989) 143:3470-5.
99. Voronov E, Dayan M, Zinger H, Gayvoronsky L, Lin JP, Iwakura Y, et al. IL-1 beta-deficient mice are resistant to induction of experimental SLE. Eur Cytokine Netw (2006) 17:109-16.
100. McCarthy EM, Smith S, Lee RZ, Cunnane G, Doran MF, Donnelly S, et al. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. Rheumatology (Oxford) (2014) 53:1586-94. doi:10.1093/rheumatology/ket428.
101. Chen J, Hartono JR, John R, Bennett M, Zhou XJ, Wang Y, et al. Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4. Kidney Int (2011) 80:504-15. doi:10.1038/ki.2011.140.
102. Sun KH, Yu CL, Tang SJ, Sun GH. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis. Immunology (2000) 99:352-60. doi:10.1046/j.1365-2567.2000.00970.x.
103. Baer PC, Wegner B, Geiger H. Effects of mycophenolic acid on IL-6 expression of human renal proximal and distal tubular cells in vitro. Nephrol Dial Transplant (2004) 19:47-52. doi:10.1093/ndt/gfg429.
104. Yung S, Tsang RC, Sun Y, Leung JK, Chan TM. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J Am Soc Nephrol (2005) 16:3281-94. doi:10.1681/ASN.2004110917.
105. Taflin C, Favier B, Baudhuin J, Savenay A, Hemon P, Bensussan A, et al. Human endothelial cells generate Th17 and regulatory T cells under inflammatory conditions. Proc Natl Acad Sci U S A (2011) 108:2891-6. doi:10.1073/pnas.1011811108.
106. Chiu YC, Lin CY, Chen CP, Huang KC, Tong KM, Tzeng CY, et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway. J Immunol (2009) 183:2785-92. doi:10.4049/jimmunol.0802826.
107. Aringer M, Smolen JS. The role of tumor necrosis factor-alpha in systemic lupus erythematosus. Arthritis Res Ther (2008) 10:202. doi:10.1186/ar2341.
108. Kollias G, Douni E, Kassiotis G, Kontoyiannis D. The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Ann Rheum Dis (1999) 58(Suppl 1):I32-9. doi:10.1136/ard.58.2008.i32.
109. Yokoyama H, Kreft B, Kelley VR. Biphasic increase in circulating and renal TNF-alpha in MRL-lpr mice with differing regulatory mechanisms. Kidney Int (1995) 47:122-30. doi:10.1038/ki.1995.14.
110. Herrera-Esparza R, Barbosa-Cisneros O, Villalobos-Hurtado R, Avalos-Diaz E. Renal expression of IL-6 and TNFalpha genes in lupus nephritis. Lupus (1998) 7:154-8. doi:10.1191/096120398678919949.
111. Malide D, Russo P, Bendayan M. Presence of tumor necrosis factor alpha and interleukin-6 in renal mesangial cells of lupus nephritis patients. Hum Pathol (1995) 26:558-64. doi:10.1016/0046-8177(95)90253-8.
112. Debets JM, Van der Linden CJ, Dieteren IE, Leeuwenberg JF, Buurman WA. Fc-receptor cross-linking induces rapid secretion of tumor necrosis factor (cachectin) by human peripheral blood monocytes. J Immunol (1988) 141:1197-201.
113. Jacob CO, McDevitt HO. Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis. Nature (1988) 331:356-8. doi:10.1038/331356a0.
114. Kontoyiannis D, Kollias G. Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur J Immunol (2000) 30:2038-47. doi:10.1002/1521-4141(200007)30:7<2038::AID-IMMU2038>3.0.CO;2-K.
115. Yung S, Cheung KF, Zhang Q, Chan TM. Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis. Clin Dev Immunol (2013) 2013:317682. doi:10.1155/2013/317682.
116. Qing X, Pitashny M, Thomas DB, Barrat FJ, Hogarth MP, Putterman C. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol Lett (2008) 121:61-73. doi:10.1016/j.imlet.2008.08.007.
117. Lee SB, Kalluri R. Mechanistic connection between inflammation and fibrosis. Kidney Int Suppl (2010) 78(Suppl 119):S22-6. doi:10.1038/ki.2010.418.
118. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis (1992) 20:1-17. doi:10.1016/S0272-6386(12)80312-X.
119. Vleming LJ, Baelde JJ, Westendorp RG, Daha MR, van Es LA, Bruijn JA. The glomerular deposition of PAS positive material correlates with renal function in human kidney diseases. Clin Nephrol (1997) 47:158-67.
120. Nakapoulou I, Stefanaki K, Zeis PM, Papadakis J, Boletis J, Vosnidis G, et al. The glomerular distribution of laminin and fibronectin in glomerulonephritis. Histol Histopathol (1993) 8:521-6.
121. Yung S, Zhang Q, Chau MK, Chan TM. Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. Autoimmunity (2015):1-17. doi:10.3109/08916934.2015.1054027.
122. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 331:1286-92. doi:10.1056/NEJM199411103311907.
123. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int (2006) 69:213-7. doi:10.1038/sj.ki.5000054.
124. Oleksyn D, Pulvino M, Zhao J, Misra R, Vosoughi A, Jenks S, et al. Protein kinase Cbeta is required for lupus development in Sle mice. Arthritis Rheum (2013) 65:1022-31. doi:10.1002/art.37825.
125. Rastaldi MP, Ferrario F, Giardino L, Dell'Antonio G, Grillo C, Grillo P, et al. Epithelial-mesenchymal transition of tubular epithelial cells in human renal biopsies. Kidney Int (2002) 62:137-46. doi:10.1046/j.1523-1755.2002.00430.x.
126. Rastaldi MP. Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis. J Nephrol (2006) 19:407-12.
127. Yung S, Ng CY, Ho SK, Cheung KF, Chan KW, Zhang Q, et al. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-beta1 and collagen synthesis. J Autoimmun (2015) 58:111-22. doi:10.1016/j.jaut.2015.01.008.
128. Ronda N, Cravedi P, Benozzi L, Lunghi P, Bonati A, Allegri L, et al. Early proinflammatory activation of renal tubular cells by normal and pathologic IgG. Nephron Exp Nephrol (2005) 100:e77-84. doi:10.1159/000084573.
129. Koren E, Koscec M, Wolfson-Reichlin M, Ebling FM, Tsao B, Hahn BH, et al. Murine and human antibodies to native DNA that cross-react with the A and D SnRNP polypeptides cause direct injury of cultured kidney cells. J Immunol (1995) 154:4857-64.
130. Yap DY, Tang CS, Ma MK, Lam MF, Chan TM. Survival analysis and causes of mortality in patients with lupus nephritis. Nephrol Dial Transplant (2012) 27:3248-54. doi:10.1093/ndt/gfs073.
131. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med (2000) 343:1156-62.
132. Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology (2000) 47:85-118. doi:10.1016/S0162-3109(00)00188-0.
133. Copeland JW, Beaumont BW, Merrilees MJ, Pilmore HL. Epithelial-to-mesenchymal transition of human proximal tubular epithelial cells: effects of rapamycin, mycophenolate, cyclosporin, azathioprine, and methylprednisolone. Transplantation (2007) 83:809-14. doi:10.1097/01.tp.0000255680.71816.aa.
134. Dubus I, Vendrely B, Christophe I, Labouyrie JP, Delmas Y, Bonnet J, et al. Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int (2002) 62:857-67. doi:10.1046/j.1523-1755.2002.00514.x.
135. Morath C, Reuter H, Simon V, Krautkramer E, Muranyi W, Schwenger V, et al. Effects of mycophenolic acid on human fibroblast proliferation, migration and adhesion in vitro and in vivo. Am J Transplant (2008) 8:1786-97. doi:10.1111/j.1600-6143.2008.02322.x.